Aspirin and other platelet active drugs. Relationship among dose, effectiveness, and side effects.

Aspirin and other platelet active drugs. Relationship among dose, effectiveness, and side effects.

Bibliographic Details
Main Authors:	Hirsh, J, Salzman, E, Harker, L, Fuster, V, Dalen, J, Cairns, J, Collins, R
Format:	Journal article
Language:	English
Published:	1989

Similar Items

Carpe low-dose aspirin: the new anti-cancer face of an old anti-platelet drug
by: Annachiara Mitrugno, et al.
Published: (2018-11-01)

Platelet inhibition by low-dose aspirin is not influenced by body mass or weight
by: Sean P. Heffron, et al.
Published: (2022-11-01)

Effects of Low-Dose Aspirin Therapy on Thermoregulation in Firefighters
by: Serina J. McEntire, et al.
Published: (2015-09-01)

Artificial intelligence, platelets and aspirin
by: Giovanni de Gaetano
Published: (2024-03-01)

Drug therapy - Low-dose aspirin for the prevention of atherothrombosis
by: Patrono, C, et al.
Published: (2005)

Better than any pill - and no side effects! Healthy lifestyles, statins and aspirin
by: Elwood, PC, et al.
Published: (2020)

Effective platelet inhibition by aspirin and clopidogrel: where are we now?
by: Tousoulis, D, et al.
Published: (2009)

The distinct effects of aspirin on platelet aggregation induced by infectious bacteria
by: Nadji Hannachi, et al.
Published: (2020-11-01)

LOW-DOSE ASPIRIN IN PREGNANCY AND EARLY-CHILDHOOD DEVELOPMENT - FOLLOW-UP OF THE COLLABORATIVE LOW-DOSE ASPIRIN STUDY IN PREGNANCY
by: Farrell, B, et al.
Published: (1995)

Low-dose aspirin for migraine prophylaxis.
by: Buring, J, et al.
Published: (1990)

Aspirin, platelet inhibition and cancer prevention
by: Paola Patrignani, et al.
Published: (2018-11-01)

The Role of Platelet and its Interaction with Aspirin
by: Luisa Fernanda Zúñiga Cerón, et al.
Published: (2016-04-01)

Low-dose aspirin, coxibs, and other NSAIDS: a clinical mosaic emerges.
by: Patrono, C, et al.
Published: (2009)

Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease.
by: Hennekens, C, et al.
Published: (1989)

Platelet Function Assays for the Diagnosis of Aspirin Resistance
by: Nameer Van Oosterom, et al.
Published: (2022-04-01)

Hepatocellular Carcinoma Prevention by Aspirin: Are Platelets the Link?
by: Hans Dieter Nischalke, et al.
Published: (2021-12-01)

Physiologically based modelling of the antiplatelet effect of aspirin: A tool to characterize drug responsiveness and inform precision dosing.
by: Alberto Giaretta, et al.
Published: (2022-01-01)

Aspirin and stroke.
by: Buring, J, et al.
Published: (1990)

Aspirin : the miracle drug /
by: 296334 Metcalf, Eric
Published: (2005)

Platelet thromboxane inhibition by low‐dose aspirin in polycythemia vera: Ex vivo and in vivo measurements and in silico simulation
by: Giovanna Petrucci, et al.
Published: (2022-12-01)

Low-dose aspirin for the prevention of atherothrombosis.
by: Patrono, C, et al.
Published: (2005)

Evaluation the effect of low-dose aspirin on endothelial dysfunction in preeclamptic patients
by: Mohammad Hashemi, et al.
Published: (2016-01-01)

Blood platelet heterogeneity at a glance: new insights into the relationship between platelet distribution width and neuropsychiatric disorders
by: Benedetta Izzi, et al.
Published: (2023-05-01)

Meyler's side effects of antimicrobial drugs /
by: Aronson, J. K.
Published: (2009)

Effect of low dose aspirin application during pregnancy on fetal congenital anomalies
by: Si Sun, et al.
Published: (2022-11-01)

Low-Dose Aspirin Augments the Anti-Inflammatory Effects of Low-Dose Lithium in Lipopolysaccharide-Treated Rats
by: Rachel Shvartsur, et al.
Published: (2022-04-01)

Blood platelets, prostaglandins and aspirin: a historical and personal rereading
by: Giovanni de Gaetano, et al.
Published: (2024-03-01)

Correction: Aspirin Delimits Platelet Life Span by Proteasomal Inhibition
Published: (2014-01-01)

Myeloproliferative Neoplasms and Aspirin: Does Increased Platelet Turnover Matter?
by: Ilgın Koçak Göktürk, et al.
Published: (2023-03-01)

Application of low dose aspirin in pre-eclampsia
by: Yu Ren, et al.
Published: (2023-03-01)

The pulmonary embolism prevention (PEP) trial: Effects of low-dose aspirin on major vascular events in patients with hip fracture
by: Prentice, C, et al.
Published: (1999)

Building the process-drug–side effect network to discover the relationship between biological Processes and side effects
by: Song Min, et al.
Published: (2011-03-01)

Stronger inhibitory effects of ticagrelor plus aspirin compared with clopidogrel plus aspirin on arachidonic acid induced platelet aggregation in patients with acute coronary syndrome with PCI
Published: (2020-10-01)

Effect of vitamins and aspirin on markers of platelet activation, oxidative stress and homocysteine in people at high risk of dementia.
by: Clarke, R, et al.
Published: (2003)

Aspirin for thromboembolic complication prevention in cardiovascular disease: dose optimization and adverse effect minimization
by: A. N. Britov
Published: (2006-12-01)

Understanding the dosing-time-dependent antihypertensive effect of valsartan and aspirin through mathematical modeling
by: Javiera Cortés-Ríos, et al.
Published: (2023-03-01)

A Beneficial Effect of Low-Dose Aspirin in a Murine Model of Active Tuberculosis
by: Vera Marie Kroesen, et al.
Published: (2018-04-01)

The effects of corticosteroids and nonsteroidal anti-inflammatory drugs, including aspirin, on coagulation
by: Eric Hodgson
Published: (2015-09-01)

Age and Aspirin Dosing in Secondary Prevention of Atherosclerotic Cardiovascular Disease
by: Guillaume Marquis‐Gravel, et al.
Published: (2024-02-01)

Benefit of heparin plus aspirin vs aspirin alone in unstable angina.
by: Collins, R, et al.
Published: (1996)